biostudies-literatureHariharaputhiran SNational Heart Foundation of Australia1519-1528https://www.ebi.ac.uk/biostudies/studies/S-EPMC9804480biostudies-literatureUnknown24(9)<h4>Aims</h4>Contemporary long-term survival following a heart failure (HF) hospitalization is uncertain. We evaluated survival up to 10 years after a HF hospitalization using national data from Australia and New Zealand, identified predictors of survival, and estimated the attributable loss in life expectancy.<h4>Methods and results</h4>Patients hospitalized with a primary diagnosis of HF from 2008-2017 were identified and all-cause mortality assessed by linking with Death Registries. Flexible parametric survival models were used to estimate survival, predictors of survival and loss in life expectancy. A total of 283 048 patients with HF were included (mean age 78.2 ± 12.3 years, 50.8% male). Of these, 48.3% (48.1-48.5) were surviving by 3 years, 34.1% (33.9-34.3) by 5 years and 17.1% (16European journal of heart failureLong-term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand.PMC9804480101186Peng YHossain SChan WAdams RRanasinghe INgo LAli AVisvanathan RHariharaputhiran SfalseLong-term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand.<h4>Aims</h4>Contemporary long-term survival following a heart failure (HF) hospitalization is uncertain. We evaluated survival up to 10 years after a HF hospitalization using national data from Australia and New Zealand, identified predictors of survival, and estimated the attributable loss in life expectancy.<h4>Methods and results</h4>Patients hospitalized with a primary diagnosis of HF from 2008-2017 were identified and all-cause mortality assessed by linking with Death Registries. Flexible parametric survival models were used to estimate survival, predictors of survival and loss in life expectancy. A total of 283 048 patients with HF were included (mean age 78.2 ± 12.3 years, 50.8% male). Of these, 48.3% (48.1-48.5) were surviving by 3 years, 34.1% (33.9-34.3) by 5 years and 17.1% (162022-01-01T00:00:00Z2022 Sep2025-04-05T12:09:47.51Z2025-04-05T12:09:47.51ZS-EPMC98044803574812410.1002/ejhf.2595